Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
Exagen Inc. (Nasdaq: XGN), a leader in autoimmune testing solutions, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Exagen Inc. (Nasdaq: XGN), a leader in autoimmune testing solutions, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The event is scheduled for August 13-15, 2024, at the InterContinental Boston Hotel in Boston, MA.
John Aballi, Exagen's President and CEO, will engage in a fireside chat on Wednesday, August 14th, at 2:30 PM ET. Interested parties can access the webcast of the presentation through a link available on Exagen's investor relations website.
This participation highlights Exagen's commitment to engaging with investors and showcasing its position in the autoimmune testing market. The conference provides an opportunity for the company to share insights into its growth strategies and recent developments in the field of autoimmune diagnostics.
Details
News Market Reaction – XGN
The recorded move for XGN in the trading session of this news was +1.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 44th Annual Growth Conference, which takes place August 13-15, 2024, at the InterContinental Boston Hotel in Boston, MA. John Aballi, Exagen’s President and Chief Executive Officer will participate in a fireside chat on Wednesday, August 14th, at 2:30 PM ET. Interested parties may access the webcast of the presentation using a link on Exagen’s website at https://investors.exagen.com/events.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.
For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).
Contact:
Ryan Douglas
Exagen Inc.
ir@exagen.com
760.560.1525
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.